News
He affirmed that the new drug "could take the epidemic to the history books," according to Mother Jones.Yeztugo, based on the ...
While Gilead Sciences’ HIV prevention drug lenacapavir got approved by the US FDA, its made-in-India generic versions may be ...
The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...
The visit also served as an opportunity to explore how UNAIDS can support South Africa’s G20 Presidency and the country’s ...
The breakthrough double injection won’t be cheap in the US, although scientists argue it could (and should) be.
Winnie Byanyima says her organization has lost almost 50% of its funding, a gap that is undermining global efforts to combat ...
US approves breakthrough HIV jab – but aid cuts mean it may not get to millions in need - FDA approval paves the way for the ...
Gilead's FDA-approved Yeztugo, a twice-yearly injectable HIV PrEP, showed near-perfect trial efficacy but faces backlash over ...
Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...
The US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV -- a move ...
1d
Health and Me on MSNNew HIV Prevention Shot Approved — But Access Remains A QuestionThe U.S. approved a twice-yearly HIV prevention shot that’s highly effective, but concerns about cost, access, and global ...
1d
Monitor on MSNNew HIV prevention drug to cost Shs102mThe drug is coming at a time when several studies aimed at finding an HIV cure or vaccine failed to yield expected results, even as the world races to end HIV/AIDs as a public health threat by 2030.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results